Research Topics
| A N FreedmanSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemopreventionAndrew N Freedman
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 95:526-32. 2003..67% or higher for breast cancer chemoprevention. However, tamoxifen use has been associated with adverse outcomes, and not all eligible women have a positive benefit/risk ratio...- Colorectal cancer risk prediction tool for white men and women without known susceptibilityAndrew N Freedman
Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, EPN 4005 MSC 7344, Bethesda, MD 20892 7344, USA
J Clin Oncol 27:686-93. 2009.... - Cancer risk prediction models: a workshop on development, evaluation, and applicationAndrew N Freedman
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 97:715-23. 2005.... - Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translationAndrew N Freedman
National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7393, USA
J Natl Cancer Inst 102:1698-705. 2010.... - US physicians' attitudes toward genetic testing for cancer susceptibilityA N Freedman
Division of Cancer Control and Population Sciences, National Cancer Institute NIH, EPN 4005 MSC 7344, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
Am J Med Genet A 120:63-71. 2003..Results of this national survey underscore the need to provide physicians with clear guidelines on the use of genetic cancer susceptibility tests and effective medical training on their appropriate implementation... - Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physiciansL Wideroff
Applied Research Program Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Med Genet 42:749-55. 2005.... - What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National SurveyK Robin Yabroff
Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD 20892 7344, USA
Cancer Epidemiol Biomarkers Prev 13:723-32. 2004.... - Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screeningBarry I Graubard
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 19:2430-6. 2010..Because MRI screening is costly and has limited specificity, estimates of the numbers of U.S. women with ?20% breast cancer risk would be useful... - Laypersons' responses to the communication of uncertainty regarding cancer risk estimatesPaul K J Han
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Med Decis Making 29:391-403. 2009..To explore laypersons' responses to the communication of uncertainty associated with individualized cancer risk estimates and to identify reasons for individual differences in these responses... - Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative studyPaul K J Han
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
Health Expect 12:4-17. 2009..To explore laypersons' understanding of individualized cancer risk estimates, and to identify conceptual problems that may limit this understanding... - Physician use of genetic testing for cancer susceptibility: results of a national surveyLouise Wideroff
National Cancer Institute, Division of Cancer Control and Population Sciences, Bethesda, Maryland 20892 7344, USA
Cancer Epidemiol Biomarkers Prev 12:295-303. 2003..39; 95% CI, 0.23-0.66%). These findings underscore the importance of establishing effective clinical approaches to test use and promoting physician education to facilitate communication with patients about cancer genetics... - Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityAsad Umar
Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
J Natl Cancer Inst 96:261-8. 2004.... - Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview SurveyLouise Wideroff
National Cancer Institute, Division of Cancer Control and Population Sciences, National Institutes of Health, Bethesda, MD 20892 7344, USA
Community Genet 6:147-56. 2003..This study explores factors associated with differential awareness of genetic tests for increased cancer risk in the US... - Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. womenErika A Waters
Cancer Prevention Fellowship Program, Center for Cancer Training, Health Communication and Informatics Research Branch Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 19:443-6. 2010..Tamoxifen can reduce the risk of developing invasive estrogen receptor-positive breast cancer by 49%, but it is unknown how many women in the United States are taking tamoxifen for primary prevention of breast cancer... - Prevalence and correlates of repeat mammography among women aged 55-79 in the Year 2000 National Health Interview SurveyWilliam Rakowski
Department of Community Health and The Center for Gerontology and Health Care Research, Brown University, Providence, RI 02912, USA
Prev Med 39:1-10. 2004..This study examines the prevalence and cross-sectional correlates of repeat mammography, among women aged 55-79, using a 12-month (N = 3,502) and a 24-month interval (N = 3,491)... - Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibilitySusan Thomas Vadaparampil
Health Outcomes and Behavior Program, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
Am J Med Genet A 135:41-6. 2005..At that time, one-quarter of the physicians considered advertisements to play an important role in their clinical decision making, suggesting attention to other sources of information and additional factors...